The FDA has now approved booster shots of the Pfizer COVID-19 vaccine for adolescents between the ages of 12 and 15.
– The FDA has approved booster shots of the Pfizer COVID-19 vaccine for adolescents between the ages of 12 and 15.
“I was at basketball practice, and I got in the car, and my mom was like, ‘You’re going to get your booster today,'” said 15-year-old Jayna Khatti. “I was just going to sit at home, get ready for school, but this is much more exciting.” At Campbell Pharmacy in North Dallas, families flooded in within minutes of hearing that their 12 to 15 year-olds were eligible for the booster.
“Anything we can do to do our part to slow this thing down, we’re all for it,” said parent John McFarland. “Excited to see that it was approved and run right up here.”
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
COVID live updates: More than 100,000 Americans hospitalized with COVID-19LATEST: New York City Mayor Eric Adams insisted that schools will stay open for in-person leaning despite the rapidly rising number of COVID cases.
Read more »
FDA authorizes Pfizer Covid-19 vaccine boosters for 12- to 15-year-oldsThe US kicked off 2022 amid a massive Covid-19 case spike — driven by the highly contagious Omicron variant — that some experts warn will be different than any other time in the pandemic.
Read more »
FDA expands Pfizer COVID-19 boosters for 12- to 15-year-olds as omicron surgesThe U.S. is expanding COVID-19 boosters as it confronts the omicron surge, with the FDA allowing extra Pfizer shots for children as young as 12.
Read more »
FDA expands Pfizer COVID-19 vaccine booster for ages 12 to 15The FDA expanded Pfizer’s COVID-19 vaccine booster for kids as young as 12. Final approval from the CDC is still needed.
Read more »
Interval between Moderna COVID-19 vaccine second shot and booster still six months -FDAThe interval between receiving a second dose of Moderna's COVID-19 vaccine and a booster dose remains unchanged at six months, U.S. Food and Drug Administration Acting Commissioner Janet Woodcock said on Monday.
Read more »